New radioactive therapy shows promise for Tough-to-Treat prostate cancer
NCT ID NCT07441837
First seen Mar 09, 2026 · Last updated May 20, 2026 · Updated 11 times
Summary
This study tests a new radioactive drug, terbium-161 PSMA, in 60 men with advanced prostate cancer that has spread and stopped responding to standard treatments. The goal is to see if it can shrink tumors and improve quality of life. Participants will receive three doses, six weeks apart, and be monitored for side effects and response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anadolu Sağlık Merkezi
Istanbul, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ankara University Medical School Dept of Nuclear Medicine
Ankara, 06590, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
-
Bilkent City Hospital
Ankara, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Memorial Sisli Hospital
Istanbul, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.